Exhibit 107
Calculation of Filing Fee Tables
FORM S-3
(Form Type)
Biora Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security | Fee | Amount | Proposed | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||
Fees to Be Paid | Equity | Common stock, par value $0.001 per share(1) | Rule 457(c) | 2,227,053(2) | $0.72(3) | $ | 1,603,478.16 | (3) | 0.00014760 | $ | 236.67 | |||||||||||
Fees Previously Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||||||
| Total Offering Amounts |
| $ | 1,603,478.16 | $ | 236.67 | ||||||||||||||||
|
| |||||||||||||||||||||
| Total Fees Previously Paid |
| — | |||||||||||||||||||
|
| |||||||||||||||||||||
| Total Fee Offsets |
| — | |||||||||||||||||||
|
| |||||||||||||||||||||
| Net Fee Due |
| $ | 236.67 | ||||||||||||||||||
|
|
(1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended, this registration statement also covers such an indeterminate amount of shares of common stock as may become issuable to prevent dilution resulting from stock splits, stock dividends and similar events. |
(2) | The amount registered consists of up to 2,227,053 shares of common stock, par value $0.001 per share, issuable upon exercise of warrants to purchase common stock. |
(3) | Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on The Nasdaq Global Market on May 14, 2024 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act). |